AG

Adam Gazzaley

Founder & Executive Director of Neuroscape at UCSF; Co-Founder, Board Member & Chief Science Advisor at Akili and JAZZ VP

San Francisco, California

Invests in

  • Min Investment:

    $100,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $1,500,000.00

Skills

EEG
Cognition
MRI
Clinical Research
Neuroscience
Research Design
Statistics
Psychiatry
Cognitive Neuroscience
Psychology
Scientific Writing
Science
Experimental Design
Neurology
Neuroimaging
SPSS
Electrophysiology
fMRI
Literature Reviews
Immunohistochemistry

Education

Work Experience

2005

  • Professor of Neurology, Psychiatry and Physiology

    2005

  • Executive Director, Neuroscape

    2017

    Neuroscape is a translational neuroscience center at UCSF engaged in technology creation and scientific research to better assess and optimize brain function of both healthy and impaired individuals.

  • Co-Founder and Chief Science Advisor

    2011

    At Akili, we're in the process of building clinically-validated cognitive therapeutics, assessments, and diagnostics that look and feel like high-quality video games. Our aim is to develop a new type of Electronic Medicineā„¢ that can be deployed remotely directly to any patient anywhere, prescribed and tracked by physicians, with the potential to be developed at a fraction of the cost of traditional medical approaches

  • Co Founder and Chief Scientist

    2015

    JAZZ Venture Partners invests in experiential technologies (XTech) that improve human performance -- emerging companies leveraging the convergence of new digital technology platforms (e.g. virtual and augmented reality, immersive videogaming, artificial intelligence, deep learning, brain-computer interfaces, robotics) with recent advances in neuroscience that are creating entirely new ways to improve the human experience. These companies are impacting multiple $100+ billion industries including health, mind-body wellness, peak mental and physical acuity, accelerated learning and training, sports, and entertainment.

2018 - 2021

  • Co-Founder and Chief Science Advisor

    2018 - 2021